NCT00028821View on ClinicalTrials.gov

2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

April 30, 2006

Conditions
Refractory Multiple MyelomaStage III Multiple MyelomaUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

2-methoxyestradiol

Given orally

OTHER

pharmacological study

Correlative studies

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

55905

Mayo Clinic, Rochester

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00028821 - 2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter